Angela J. Arumpanayil
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Angela J. Arumpanayil has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Chris Winkelman
Frances Payne Bolton School of Nursing, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, OH 44106, USA
1 shared publication - Christopher P. Brandt
Case Western Reserve University, School of Medicine, Cleveland, Ohio; MetroHealth Medical Center, Cleveland, Ohio
1 shared publication - Jeremy Md Lipman
Digestive Diseases Institute, Cleveland Clinic, Cleveland, Ohio; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio
1 shared publication - Kelly K. McConnell
Case Western Reserve University, School of Nursing, Cleveland, Ohio
1 shared publication - Michael R. Pelyak
Case Western Reserve University, School of Nursing, Cleveland, Ohio
1 shared publication
Latest Publications
- 1 November 2018
- Published by Elsevier in Journal of Surgical Education
- Vol. 75 (6) , 1491-1497
Attitudes Toward Communication and Collaboration After Participation in a Mock Page Program: A Pilot of an Interprofessional Approach to Surgical Residency Preparation
- 1 November 2018
- Published by Elsevier in Journal of Surgical Education
- Vol. 75 (6) , 1491-1497
Attitudes Toward Communication and Collaboration After Participation in a Mock Page Program: A Pilot of an Interprofessional Approach to Surgical Residency Preparation
- 1 January 2013
- Published by Wolters Kluwer Health in Dimensions of Critical Care Nursing
- Vol. 32 (5) , 229-236
Inhaled Epoprostenol to Support the Severely Hypoxemic Patient With Acute Respiratory Distress Syndrome
This article presents a case study demonstrating various rescue therapies considered in the care of a patient with severe, refractory hypoxemia secondary to acute respiratory distress syndrome. In particular, inhaled epoprostenol (Flolan) is becoming an increasingly common alternative to nitric oxide in the treatment of severe, refractory hypoxemia. Research comparing the 2 inhaled vasodilators suggests that epoprostenol is equally efficacious, easier to administer, less costly, and has fewer adverse effects. This article, using a case study approach, discusses the practical implications of this emerging therapy.
- 1 January 2013
- Published by Wolters Kluwer Health in Dimensions of Critical Care Nursing
- Vol. 32 (5) , 229-236
Inhaled Epoprostenol to Support the Severely Hypoxemic Patient With Acute Respiratory Distress Syndrome
This article presents a case study demonstrating various rescue therapies considered in the care of a patient with severe, refractory hypoxemia secondary to acute respiratory distress syndrome. In particular, inhaled epoprostenol (Flolan) is becoming an increasingly common alternative to nitric oxide in the treatment of severe, refractory hypoxemia. Research comparing the 2 inhaled vasodilators suggests that epoprostenol is equally efficacious, easier to administer, less costly, and has fewer adverse effects. This article, using a case study approach, discusses the practical implications of this emerging therapy.